期刊
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY
卷 22, 期 12, 页码 1067-1076出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0192-0561(00)00075-8
关键词
cancer; immunotherapy; thymosin alpha 1
Many studies have explored the effects of immunotherapy, alone or in combination with conventional therapies, on both experimental and human cancers. Evidence has been provided that combined treatments with thymosin alpha 1 (T alpha 1) and low doses of interferon (IFN) or interleukin (IL)-2 are highly effective in restoring several immune responses depressed by tumor growth and/or cytostatic drugs. In addition, when combined with specific chemotherapy, they are able to increase the anti-tumor effect of chemotherapy while markedly reducing the general toxicity of the treatment. The advantages of using this combined chemo-immunotherapeutic approach in experimental and human cancers are reviewed in this issue. (C) 2000 International Society for Immunopharmacology. Published by Elsevier Science Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据